N-pyridazin-3-yl-3-[(E)-3-[6-[[5-(trifluoromethyl)-2-pyridinyl]oxy]pyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide

InChIKey	`WBFGOFIEIRLCBO-DAFODLJHSA-N`
Compound Name	N-pyridazin-3-yl-3-[(E)-3-[6-[[5-(trifluoromethyl)-2-pyridinyl]oxy]pyrazin-2-yl]prop-2-enyl]azetidine-1-carboxamide
Canonical SMILES	`O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Cross-Family
Avg pChEMBL	6.38
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P28223	HTR2A	Homo sapiens	Human	PF00001	6.6	Ki	ChEMBL
Q5BJF2	TMEM97	Homo sapiens	Human	PF05241	6.4	Ki	ChEMBL
Q99720	SIGMAR1	Homo sapiens	Human	PF04622	6.3	Ki	ChEMBL
P18825	ADRA2C	Homo sapiens	Human	PF00001	6.2	Ki	ChEMBL